teneligliptin
Ligand Summary
A long-acting, orally bioavailable, pyrrolidine-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Teneligliptin may also reduce plasma triglyceride levels through a sustained increase in GLP-1 levels.
PubChem: 11949652
Guide to Pharmacology: 9906
ChEMBL: CHEMBL2147777
DrugCentral: 4895
LyCHI: RPKLVWPN4ZB3
Target Activities
11 Activities
Items per page:
1 – 10 of 11
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
Kd | ||||||
Kd | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | INHIBITOR | |||||
IC50 | ||||||